Antibody gene therapy: old wine in a new bottle.
Chen
Lieping
L
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D015703:Antigens, CD; D019496:Cancer Vaccines / Q000235:genetics / Q000627:therapeutic use; D015316:Genetic Therapy / Q000379:methods*; D007128:Immunoglobulin Fragments / Q000235:genetics*; D008024:Ligands; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D017475:Receptors, Nerve Growth Factor / Q000276:immunology; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology; D014162:Transfection; D053261:Tumor Necrosis Factor Receptor Superfamily, Member 9
D015703:Antigens, CD; D019496:Cancer Vaccines; D007128:Immunoglobulin Fragments; D008024:Ligands; D017475:Receptors, Nerve Growth Factor; D018124:Receptors, Tumor Necrosis Factor; C505715:Tnfrsf9 protein, mouse; D053261:Tumor Necrosis Factor Receptor Superfamily, Member 9; C055966:immunoglobulin Fv